At present predictive biomarkers to identify underlying resistance mechanisms and guide effective post-AI therapy for individual patients are missing
Management of Aromatase Inhibitor-Resistant Disease with Estrogen, Selective Estrogen Receptor Down-Regulators, and Other Agents / Oakman C; Santarpia L; Moretti E; Biganzoli L; Di Leo A. - In: CURRENT BREAST CANCER REPORTS. - ISSN 1943-4596. - ELETTRONICO. - (2011), pp. 24-33.
Management of Aromatase Inhibitor-Resistant Disease with Estrogen, Selective Estrogen Receptor Down-Regulators, and Other Agents
MORETTI, ERICA;
2011
Abstract
At present predictive biomarkers to identify underlying resistance mechanisms and guide effective post-AI therapy for individual patients are missing
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
